EKF Diagnostics Holdings plc Stock

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:27 2024-05-28 am EDT 5-day change 1st Jan Change
32 GBX -3.03% Intraday chart for EKF Diagnostics Holdings plc -1.69% +1.11%
Sales 2023 52.61M 67.12M Sales 2024 * 54.68M 69.76M Capitalization 145M 185M
Net income 2023 2M 2.55M Net income 2024 * 3M 3.83M EV / Sales 2023 2.66 x
Net cash position 2023 3.63M 4.63M Net cash position 2024 * 9.78M 12.47M EV / Sales 2024 * 2.48 x
P/E ratio 2023
60.9 x
P/E ratio 2024 *
34 x
Employees 356
Yield 2023
3.79%
Yield 2024 *
-
Free-Float 94.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.03%
1 week-1.69%
Current month+11.11%
1 month+15.94%
3 months+18.74%
6 months+14.29%
Current year+1.11%
More quotes
1 week
31.68
Extreme 31.6771
33.00
1 month
27.35
Extreme 27.35
33.80
Current year
23.00
Extreme 23
34.00
1 year
22.20
Extreme 22.2
38.22
3 years
22.20
Extreme 22.2
86.80
5 years
16.58
Extreme 16.5794
86.80
10 years
7.00
Extreme 7
86.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 23-09-11
Chairman 59 09-11-25
- -
Members of the board TitleAgeSince
Director/Board Member 72 16-04-07
Director/Board Member 49 21-06-30
Chairman 59 09-11-25
More insiders
Date Price Change Volume
24-05-28 32 -3.03% 945,773
24-05-24 33 0.00% 347,081
24-05-23 33 +1.54% 635,777
24-05-22 32.5 +0.93% 2,125,884
24-05-21 32.2 -1.08% 66,041

Delayed Quote London S.E., May 28, 2024 at 11:35 am EDT

More quotes
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.32 GBP
Average target price
0.34 GBP
Spread / Average Target
+6.25%
Consensus